The global pediatric perfusion market size was estimated to be USD 0.579 billion in 2023 and is expected to reach at USD 1.06 billion by 2034 with a CAGR of 5.67% during the forecast period 2024-2034. Surge in introduction of advanced technological products, increasing number of pediatric cardiac surgery centers, growing favorable government initiatives & reimbursement policies, rising prevalence of congenital heart disease (CHD) or congenital disabilities among children, surge in demand for effective & safe treatment approaches to cure heart defects, increasing number of organ transplants, growing partnerships, collaborations, mergers & acquisitions within market players, and rising approval of innovative pediatric perfusion systems by regulatory authorities are some of the key factors boosting the market growth.
Rising approval of innovative pediatric perfusion systems by regulatory authorities is predicted to boost the market growth during the forecast period. Pediatric perfusion is a medical device used to facilitate the circulation of blood within the body of a pediatric patient. It plays a critical role in maintaining stable blood pressure and oxygen levels in pediatric patients, ensuring that blood is adequately distributed to all parts of their body. Therefore, companies are actively promoting the extensive utilization of advanced technologies, thus advancing the pediatric perfusion industry. For instance, in January 2022, XVIVO has obtained '510(k) clearance' from the U.S. FDA for its portable organ perfusion system, known as the Kidney Assist Transport. This system enables the continuous, cold, pulsatile perfusion of donor kidneys with an oxygenated preservation solution during the entire transportation process, from the donor to the recipient, in transplant procedures.
By product, pediatric oxygenators was the highest revenue-grossing segment in the global pediatric perfusion market in 2023 owing to rising focus on developing and introducing groundbreaking oxygenators to enhance patient results, streamline the process, & enhance safety in cardiopulmonary bypass procedures by manufacturers & enterprises and increasing regulatory approvals. For instance, in March 2023, LivaNova PLC, a prominent medical technology and innovation company, has announced that it has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Essenz Heart-Lung Machine (HLM). This clearance from the FDA marks the commencement of the commercial launch of Essenz in the United States. Additionally, the company has also recently secured approval for the Essenz HLM from Health Canada and the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). Additionally, monitoring system is predicted to grow at fastest CAGR during the forecast period owing to surge in prioritizing patient safety, leveraging technological advancements to offer real-time data & feedback during cardiac surgeries, growing number of cardiac surgeries, increasing demand for continuous monitoring and adherence to regulatory standards.
By end-user, hospitals was the highest revenue-grossing segment in the global pediatric perfusion market in 2023 owing to the growing prevalence of cardiac & respiratory conditions, surge in number of organ transplantation procedures within hospitals, and rising acquisitions within market players. For instance, in August 2022, Medtronic plc, a prominent global healthcare technology leader, has disclosed its plans to acquire Affera, Inc., a privately held medical technology company based in the Boston area. This acquisition aims to broaden Medtronic's range of advanced cardiac ablation products and accessories, addressing the requirements of physicians within a continually expanding patient demographic. Additionally, cardiac centers is predicted to grow at fastest CAGR during the forecast period owing to the increasing trend among patients to opt for surgical interventions at specialized cardiac centers, rising prevalence of cardiovascular diseases, surge in number of cardiac specialty centers, and the expansion in the number of specialized cardiac centers has resulted in a higher volume of patients seeking care at these facilities.
North America region is anticipated for the highest revenue share during the forecast period owing to the presence of leading market players, rising awareness regarding accessible technologies among the public & healthcare stakeholders, increasing occurrence of coronary heart disease (CHD), surge in well-developed healthcare infrastructure, growing number of organ transplant procedures, escalating technological advancements, and rising funding from market plyers. For instance, in May 2023, The Children's Hospital of Philadelphia (CHOP) has unveiled a generous multi-million-dollar donation from long-time supporters of CHOP's Cardiac Center. This donation will be used to establish the Topolewski Pediatric Heart Valve Center. The funds will be instrumental in supporting CHOP's Valve Center, which is designated as a Frontier program, in conducting research on the treatment of valve-related illnesses and furthering our understanding of these complex conditions. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in advanced healthcare infrastructure, growing prevalence of cardiovascular disease (CVD), increasing government initiatives, rising awareness regarding CPB machines, surge in research & development activities, growing investment by major market players. For instance, in September 2022, Terumo Cardiovascular, a prominent global leader in medical devices for cardiac and vascular surgery, has inaugurated a manufacturing plant in Cartago's La Lima Free Zone (LLFZ), with a total investment of $42 million. These new facilities house the Perfusion Circuit Technology and Manufacturing Center, making it the first company to produce this line of medical equipment in Costa Rica.
Rising approval of innovative pediatric perfusion systems by regulatory authorities is predicted to boost the market growth during the forecast period. Pediatric perfusion is a medical device used to facilitate the circulation of blood within the body of a pediatric patient. It plays a critical role in maintaining stable blood pressure and oxygen levels in pediatric patients, ensuring that blood is adequately distributed to all parts of their body. Therefore, companies are actively promoting the extensive utilization of advanced technologies, thus advancing the pediatric perfusion industry. For instance, in January 2022, XVIVO has obtained '510(k) clearance' from the U.S. FDA for its portable organ perfusion system, known as the Kidney Assist Transport. This system enables the continuous, cold, pulsatile perfusion of donor kidneys with an oxygenated preservation solution during the entire transportation process, from the donor to the recipient, in transplant procedures.
By product, pediatric oxygenators was the highest revenue-grossing segment in the global pediatric perfusion market in 2023 owing to rising focus on developing and introducing groundbreaking oxygenators to enhance patient results, streamline the process, & enhance safety in cardiopulmonary bypass procedures by manufacturers & enterprises and increasing regulatory approvals. For instance, in March 2023, LivaNova PLC, a prominent medical technology and innovation company, has announced that it has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Essenz Heart-Lung Machine (HLM). This clearance from the FDA marks the commencement of the commercial launch of Essenz in the United States. Additionally, the company has also recently secured approval for the Essenz HLM from Health Canada and the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). Additionally, monitoring system is predicted to grow at fastest CAGR during the forecast period owing to surge in prioritizing patient safety, leveraging technological advancements to offer real-time data & feedback during cardiac surgeries, growing number of cardiac surgeries, increasing demand for continuous monitoring and adherence to regulatory standards.
By end-user, hospitals was the highest revenue-grossing segment in the global pediatric perfusion market in 2023 owing to the growing prevalence of cardiac & respiratory conditions, surge in number of organ transplantation procedures within hospitals, and rising acquisitions within market players. For instance, in August 2022, Medtronic plc, a prominent global healthcare technology leader, has disclosed its plans to acquire Affera, Inc., a privately held medical technology company based in the Boston area. This acquisition aims to broaden Medtronic's range of advanced cardiac ablation products and accessories, addressing the requirements of physicians within a continually expanding patient demographic. Additionally, cardiac centers is predicted to grow at fastest CAGR during the forecast period owing to the increasing trend among patients to opt for surgical interventions at specialized cardiac centers, rising prevalence of cardiovascular diseases, surge in number of cardiac specialty centers, and the expansion in the number of specialized cardiac centers has resulted in a higher volume of patients seeking care at these facilities.
North America region is anticipated for the highest revenue share during the forecast period owing to the presence of leading market players, rising awareness regarding accessible technologies among the public & healthcare stakeholders, increasing occurrence of coronary heart disease (CHD), surge in well-developed healthcare infrastructure, growing number of organ transplant procedures, escalating technological advancements, and rising funding from market plyers. For instance, in May 2023, The Children's Hospital of Philadelphia (CHOP) has unveiled a generous multi-million-dollar donation from long-time supporters of CHOP's Cardiac Center. This donation will be used to establish the Topolewski Pediatric Heart Valve Center. The funds will be instrumental in supporting CHOP's Valve Center, which is designated as a Frontier program, in conducting research on the treatment of valve-related illnesses and furthering our understanding of these complex conditions. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in advanced healthcare infrastructure, growing prevalence of cardiovascular disease (CVD), increasing government initiatives, rising awareness regarding CPB machines, surge in research & development activities, growing investment by major market players. For instance, in September 2022, Terumo Cardiovascular, a prominent global leader in medical devices for cardiac and vascular surgery, has inaugurated a manufacturing plant in Cartago's La Lima Free Zone (LLFZ), with a total investment of $42 million. These new facilities house the Perfusion Circuit Technology and Manufacturing Center, making it the first company to produce this line of medical equipment in Costa Rica.
Segmentation: Pediatric Perfusion Market Report 2023 - 2034
Pediatric Perfusion Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Pediatric Arterial Filters
- Pediatric Blood Pumps
- Pediatric Oxygenators
- Monitoring Systems
- Pediatric Cannulae
- Others
Pediatric Perfusion Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Hospitals
- Cardiac Centers
- Others
Pediatric Perfusion Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Pediatric Perfusion Market: Product Estimates & Trend Analysis
8. Pediatric Perfusion Market: End-user Estimates & Trend Analysis
9. Regional Market Analysis
10. North America Pediatric Perfusion Market
11. Europe Global Pediatric Perfusion Market
12. Asia Pacific Global Pediatric Perfusion Market
13. Latin America Global Pediatric Perfusion Market
14. MEA Global Pediatric Perfusion Market
15. Competitor Analysis
16. Company Profiles
Companies Mentioned
- Terumo Cardiovascular Systems Corporation
- BL Lifesciences
- LivaNova PLC
- Cardinal Health
- Medtronic
- Getinge AB
- EUROSETS
- MEDIVATORS Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 0.58 Billion |
| Forecasted Market Value ( USD | $ 1.06 Billion |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 8 |
